Chemical activators of Olr1602 can facilitate its functional activation through various biochemical pathways. Zinc Sulfate, for instance, can directly interact with Olr1602, where the zinc ions bind to specific sites on Olr1602, leading to conformational changes that enhance its activity. This mechanism ensures that the protein adopts an active structure, allowing it to fulfill its biological role. Similarly, Forskolin elevates intracellular cAMP levels through the activation of adenylate cyclase, which in turn activates protein kinase A (PKA). Activated PKA can then target Olr1602, phosphorylating the protein and thus promoting its activation. Another compound, Ionomycin, works by increasing intracellular calcium, which activates calcium-dependent kinases that can also phosphorylate and activate Olr1602.
In parallel, Phorbol 12-myristate 13-acetate (PMA) functions by activating protein kinase C (PKC), which leads to the phosphorylation and activation of Olr1602. Okadaic Acid contributes to the activation of Olr1602 by inhibiting the dephosphorylation of proteins, including Olr1602, by protein phosphatases. This action prevents the inactivation of Olr1602, maintaining it in an active state. Sodium Fluoride activates G proteins and inhibits phosphatases, thereby facilitating an increase in the phosphorylation and subsequent activation of Olr1602. BAY K8644 targets L-type calcium channels, leading to increased calcium influx, which can activate kinases that phosphorylate and activate Olr1602. Thapsigargin, by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leads to increased cytosolic calcium levels, which activate calcium-dependent kinases capable of phosphorylating Olr1602. Additional cAMP analogues, such as Dibutyryl-cAMP and 8-Bromo-cAMP, mimic the action of cAMP and activate PKA, which then phosphorylates Olr1602. Finally, 4-α-Phorbol directly activates PKC, which in turn can phosphorylate and activate Olr1602, while A23187, as a calcium ionophore, increases intracellular calcium levels to activate calcium-dependent kinases that phosphorylate and activate Olr1602. Each chemical operates through distinct yet interconnected pathways to ensure the activation of Olr1602, highlighting a complex network of regulatory mechanisms that control protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can directly activate Olr1602 by binding to specific sites on the protein, which can cause conformational changes that enhance its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels which can activate calcium-dependent kinases. These kinases can phosphorylate and activate Olr1602. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate and activate Olr1602. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases that dephosphorylate proteins, thus maintaining Olr1602 in an activated state by preventing its dephosphorylation. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium Fluoride activates G proteins and inhibits phosphatases, leading to increased phosphorylation and activation of Olr1602. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 specifically targets L-type calcium channels, resulting in increased calcium influx which can activate kinases that phosphorylate and activate Olr1602. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA, leading to increased cytosolic calcium which activates calcium-dependent kinases that can phosphorylate and activate Olr1602. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP acts as a cAMP analogue, activating PKA which can then phosphorylate and activate Olr1602. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP, another cAMP analogue, activates PKA which can phosphorylate and activate Olr1602. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
4-α-Phorbol activates PKC which can then phosphorylate and lead to the activation of Olr1602. | ||||||